Stem cell gene expression programs influence clinical outcome in human leukemia (original) (raw)

• Dick, J.E. Stem cell concepts renew cancer research. Blood 112, 4793–4807 (2008).
  Article CAS PubMed Google Scholar
• Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
  Article CAS PubMed Google Scholar
• Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780–783 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100, 672–679 (2008).
  Article CAS PubMed Google Scholar
• Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315–1321 (2007).
  Article CAS PubMed Google Scholar
• Dylla, S.J. et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 3, e2428 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Guzman, M.L. et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98, 2301–2307 (2001).
  Article CAS PubMed Google Scholar
• Kelly, P.N., Dakic, A., Adams, J.M., Nutt, S.L. & Strasser, A. Tumor growth need not be driven by rare cancer stem cells. Science 317, 337 (2007).
  Article CAS PubMed Google Scholar
• Taussig, D.C. et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112, 568–575 (2008).
  Article CAS PubMed Google Scholar
• Taussig, D.C. et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(−) fraction. Blood 115, 1976–1984 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593–598 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).
  Article CAS PubMed Google Scholar
• Bonnet, D. & Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730–737 (1997).
  Article CAS PubMed Google Scholar
• Pearce, D.J. et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 107, 1166–1173 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• van Rhenen, A. et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin. Cancer Res. 11, 6520–6527 (2005).
  Article CAS PubMed Google Scholar
• McKenzie, J.L., Gan, O.I., Doedens, M. & Dick, J.E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 106, 1259–1261 (2005).
  Article CAS PubMed Google Scholar
• McDermott, S.P., Eppert, K., Lechman, E., Doedens, M. & Dick, J.E. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 116, 193–200 (2010).
  Article CAS PubMed Google Scholar
• Blair, A., Hogge, D.E., Ailles, L.E., Lansdorp, P.M. & Sutherland, H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89, 3104–3112 (1997).
  Article CAS PubMed Google Scholar
• Terpstra, W. et al. Fluoroucil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood 88, 1944–1950 (1996).
  Article CAS PubMed Google Scholar
• Sarry, J.E. et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgammac-deficient mice. J. Clin. Invest. 121, 384–395 (2011).
  Article CAS PubMed Google Scholar
• Novershtern, N. et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296–309 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Georgantas, R.W. III et al. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res. 64, 4434–4441 (2004).
  Article CAS PubMed Google Scholar
• Shojaei, F. et al. Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev. Cell 8, 651–663 (2005).
  Article CAS PubMed Google Scholar
• Wagner, W. et al. Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 104, 675–686 (2004).
  Article CAS PubMed Google Scholar
• Ivanova, N.B. et al. A stem cell molecular signature. Science 298, 601–604 (2002).
  Article CAS PubMed Google Scholar
• Notta, F. et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333, 218–221 (2011).
  Article CAS PubMed Google Scholar
• Mazurier, F., Doedens, M., Gan, O.I. & Dick, J.E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat. Med. 9, 959–963 (2003).
  Article CAS PubMed Google Scholar
• Brown, K.R. & Jurisica, I. Online predicted human interaction database. Bioinformatics 21, 2076–2082 (2005).
  Article CAS PubMed Google Scholar
• Brown, K.R. et al. NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics 25, 3327–3329 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, I.H. & Eaves, C.J. Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity. Oncogene 21, 4778–4787 (2002).
  Article CAS PubMed Google Scholar
• Varnum-Finney, B. et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6, 1278–1281 (2000).
  Article CAS PubMed Google Scholar
• Karanu, F.N. et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192, 1365–1372 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Somervaille, T.C. et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4, 129–140 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Valk, P.J. et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350, 1617–1628 (2004).
  Article CAS PubMed Google Scholar
• Verhaak, R.G. et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94, 131–134 (2009).
  Article PubMed Google Scholar
• Metzeler, K.H. et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112, 4193–4201 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Schlenk, R.F. et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358, 1909–1918 (2008).
  Article CAS PubMed Google Scholar
• Mrózek, K., Marcucci, G., Paschka, P., Whitman, S.P. & Bloomfield, C.D. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109, 431–448 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Döhner, K. et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106, 3740–3746 (2005).
  Article PubMed CAS Google Scholar
• Schnittger, S. et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106, 3733–3739 (2005).
  Article CAS PubMed Google Scholar
• Thiede, C. et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107, 4011–4020 (2006).
  Article CAS PubMed Google Scholar
• Marcucci, G. et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J. Clin. Oncol. 26, 5078–5087 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bullinger, L. et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350, 1605–1616 (2004).
  Article CAS PubMed Google Scholar
• Radmacher, M.D. et al. Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood 108, 1677–1683 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499–507 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hassan, K.A., Chen, G., Kalemkerian, G.P., Wicha, M.S. & Beer, D.G. An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin. Cancer Res. 15, 6386–6390 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wong, D.J. et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2, 333–344 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gal, H. et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia 20, 2147–2154 (2006).
  Article CAS PubMed Google Scholar
• Gentles, A.J., Plevritis, S.K., Majeti, R. & Alizadeh, A.A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. J. Am. Med. Assoc. 304, 2706–2715 (2010).
  Article CAS Google Scholar
• Guzman, M.L. et al. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood 97, 2177–2179 (2001).
  Article CAS PubMed Google Scholar
• Saito, Y. et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci. Transl. Med. 2, 17ra9 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Majeti, R. et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl. Acad. Sci. USA 106, 3396–3401 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rosen, J.M. & Jordan, C.T. The increasing complexity of the cancer stem cell paradigm. Science 324, 1670–1673 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Adams, J.M. & Strasser, A. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res. 68, 4018–4021 (2008).
  Article CAS PubMed Google Scholar
• Goyama, S. et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 3, 207–220 (2008).
  Article CAS PubMed Google Scholar
• Simsek, T. et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7, 380–390 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Björnsson, J.M. et al. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Mol. Cell. Biol. 23, 3872–3883 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Loughran, S.J. et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 9, 810–819 (2008).
  Article CAS PubMed Google Scholar
• Barjesteh van Waalwijk van Doorn-Khosrovani, S. et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101, 837–845 (2003).
  Article PubMed CAS Google Scholar
• Wang, J.C. Good cells gone bad: the cellular origins of cancer. Trends Mol. Med. 16, 145–151 (2010).
  Article CAS PubMed Google Scholar
• Tenen, D.G. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3, 89–101 (2003).
  Article CAS PubMed Google Scholar
• Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
  Article Google Scholar
• Hu, Y. & Smyth, G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70–78 (2009).
  Article CAS PubMed Google Scholar